LRRK2 and Parkinson disease: The univariate analysis comparing the mean concentrations of all metabolites from sPD vs. LRRK2 PD participants revealed that 10 metabolites showed statistically significant concentration changes between the two groups (p < 0.05; q < 0.1; Supplementary Table S5).